SI-BONE (SIBN) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.09
- EPS estimate
- −$0.15
- EPS surprise
- +39.80%
- Revenue surprise
- +1.21%
- Revenue
- $56.0M
- Revenue estimate
- $55.3M
- Reported
- Aug 3, 2026
SI-BONE reported Q2 2026 results on August 3, 2026. It posted a loss of $0.09 per share, narrower than the expected $0.15 loss, a beat of 39.80%. Revenue was $56.0 million, 1.21% above the $55.3 million consensus. Compared with Q2 2025, the loss narrowed from $0.14 per share and revenue rose about 15% from $48.6 million.
All 20 quarters in the table were losses, but they have narrowed steadily. Annual losses shrank from $1.79 per share in 2022 to $1.14 in 2023, $0.76 in 2024 and $0.44 in 2025. Q4 2025 was the smallest loss shown, at $0.04. Revenue grew each year, from $106.4 million in 2022 to $201.0 million in 2025, up about 89%, including about 20% growth in 2025 alone. The first half of 2026 brought a loss of $0.19 per share against $0.29 a year earlier, on revenue up about 13%. SI-BONE beat the EPS estimate in each of the last 16 quarters; the four misses all came between Q3 2021 and Q2 2022.
Q3 results came out between November 6 and November 12 in each of the past five years. That points to early or mid-November 2026 for the next report.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 3, 2026 | −$0.15 | −$0.09 | +39.80% | $56.0M | SEC |
| Q1 2026 | May 11, 2026 | −$0.19 | −$0.10 | +46.70% | $52.6M | SEC |
| Q4 2025 | Feb 23, 2026 | −$0.13 | −$0.04 | +68.25% | $56.4M | SEC |
| Q3 2025 | Nov 10, 2025 | −$0.17 | −$0.11 | +33.89% | $48.7M | SEC |
| Q2 2025 | Aug 4, 2025 | −$0.18 | −$0.14 | +23.62% | $48.6M | SEC |
| Q1 2025 | May 5, 2025 | −$0.23 | −$0.15 | +33.54% | $47.3M | SEC |
| Q4 2024 | Feb 24, 2025 | −$0.15 | −$0.11 | +24.40% | $49.0M | SEC |
| Q3 2024 | Nov 12, 2024 | −$0.24 | −$0.16 | +33.03% | $40.3M | SEC |
| Q2 2024 | Aug 5, 2024 | −$0.28 | −$0.22 | +20.55% | $40.0M | SEC |
| Q1 2024 | May 6, 2024 | −$0.31 | −$0.27 | +12.54% | $37.9M | SEC |
| Q4 2023 | Feb 26, 2024 | −$0.28 | −$0.27 | +2.91% | $38.9M | SEC |
| Q3 2023 | Nov 6, 2023 | −$0.34 | −$0.25 | +26.99% | $34.0M | SEC |
| Q2 2023 | Aug 7, 2023 | −$0.40 | −$0.30 | +24.30% | $33.3M | SEC |
| Q1 2023 | May 1, 2023 | −$0.41 | −$0.32 | +22.42% | $32.7M | SEC |
| Q4 2022 | Feb 27, 2023 | −$0.40 | −$0.32 | +19.92% | $32.0M | SEC |
| Q3 2022 | Nov 7, 2022 | −$0.47 | −$0.41 | +13.48% | $26.4M | SEC |
| Q2 2022 | Aug 8, 2022 | −$0.49 | −$0.54 | −10.27% | $25.6M | SEC |
| Q1 2022 | May 9, 2022 | −$0.43 | −$0.52 | −22.01% | $22.4M | SEC |
| Q4 2021 | Feb 28, 2022 | −$0.39 | −$0.43 | −11.31% | $25.2M | SEC |
| Q3 2021 | Nov 8, 2021 | −$0.42 | −$0.48 | −15.08% | $22.3M | SEC |
Quarterly revenue
Frequently asked questions
When did SI-BONE (SIBN) last report earnings?
SI-BONE last reported on Aug 3, 2026, covering fiscal Q2 2026.
Did SIBN beat earnings estimates?
Yes. SI-BONE reported EPS of −$0.09 for Q2 2026 against a −$0.15 estimate — a 39.80% beat.
How much revenue did SIBN report last quarter?
SI-BONE reported $56.0M in revenue for Q2 2026, against a consensus estimate of $55.3M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.